Pfizer Limited (NSE: PFIZER)

India flag India · Delayed Price · Currency is INR
5,225.65
+94.35 (1.84%)
Nov 22, 2024, 3:30 PM IST
29.47%
Market Cap 239.06B
Revenue (ttm) 22.38B
Net Income (ttm) 6.18B
Shares Out 45.75M
EPS (ttm) 135.06
PE Ratio 38.69
Forward PE n/a
Dividend 35.00 (0.67%)
Ex-Dividend Date Aug 21, 2024
Volume 12,143
Open 5,161.00
Previous Close 5,131.30
Day's Range 5,131.35 - 5,269.25
52-Week Range 3,950.00 - 6,451.15
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare... [Read more]

Sector Healthcare
Founded 1950
Employees 1,721
Stock Exchange National Stock Exchange of India
Ticker Symbol PFIZER
Full Company Profile

Financial Performance

In 2023, Pfizer's revenue was 21.93 billion, a decrease of -9.55% compared to the previous year's 24.25 billion. Earnings were 5.51 billion, a decrease of -11.64%.

Financial Statements

News

There is no news available yet.